Harald L. Esch

455 total citations
19 papers, 340 citations indexed

About

Harald L. Esch is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Harald L. Esch has authored 19 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Harald L. Esch's work include Estrogen and related hormone effects (6 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Harald L. Esch is often cited by papers focused on Estrogen and related hormone effects (6 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Harald L. Esch collaborates with scholars based in Germany, United States and Netherlands. Harald L. Esch's co-authors include Leane Lehmann, Larry W. Robertson, Gabriele Ludewig, Patricia Kirby, Jörg Wagner, M. Metzler, Reinhard Kreiling, Cynthia Graham, Carl Haux and Annette Mehling and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Environment International and Carcinogenesis.

In The Last Decade

Harald L. Esch

19 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald L. Esch Germany 10 119 67 64 50 50 19 340
Ruth Pendlington United Kingdom 16 107 0.9× 67 1.0× 43 0.7× 153 3.1× 43 0.9× 25 473
Julie A. Skare United States 13 157 1.3× 157 2.3× 212 3.3× 103 2.1× 99 2.0× 24 513
Sourav Sikdar India 13 42 0.4× 176 2.6× 27 0.4× 15 0.3× 64 1.3× 25 490
Tânia Cristina Higashi Sawada Brazil 13 27 0.2× 82 1.2× 20 0.3× 62 1.2× 96 1.9× 17 441
Monserrat Sordo Mexico 15 147 1.2× 175 2.6× 161 2.5× 22 0.4× 171 3.4× 27 546
Martina Klarić Belgium 17 201 1.7× 63 0.9× 42 0.7× 296 5.9× 127 2.5× 31 800
Mairam Gulumian South Africa 6 37 0.3× 79 1.2× 31 0.5× 16 0.3× 180 3.6× 10 376
Camilla K. Smith United Kingdom 7 23 0.2× 102 1.5× 21 0.3× 156 3.1× 61 1.2× 9 344
Isabelle Boudry France 14 76 0.6× 82 1.2× 55 0.9× 96 1.9× 209 4.2× 24 378
Jeroen C.W. Rijk Netherlands 13 114 1.0× 140 2.1× 23 0.4× 14 0.3× 15 0.3× 21 433

Countries citing papers authored by Harald L. Esch

Since Specialization
Citations

This map shows the geographic impact of Harald L. Esch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald L. Esch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald L. Esch more than expected).

Fields of papers citing papers by Harald L. Esch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald L. Esch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald L. Esch. The network helps show where Harald L. Esch may publish in the future.

Co-authorship network of co-authors of Harald L. Esch

This figure shows the co-authorship network connecting the top 25 collaborators of Harald L. Esch. A scholar is included among the top collaborators of Harald L. Esch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald L. Esch. Harald L. Esch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Esch, Harald L., et al.. (2022). Validation of a GC- and LC-MS/MS based method for the quantification of 22 estrogens and its application to human plasma. Steroids. 186. 109077–109077. 4 indexed citations
3.
Ickstadt, Katja, et al.. (2020). Influence of breast cancer risk factors and intramammary biotransformation on estrogen homeostasis in the human breast. Archives of Toxicology. 94(9). 3013–3025. 4 indexed citations
5.
Esch, Harald L., Frank Möller, Oliver Zierau, et al.. (2019). Novel insight in estrogen homeostasis and bioactivity in the ACI rat model of estrogen-induced mammary gland carcinogenesis. Archives of Toxicology. 93(7). 1979–1992. 2 indexed citations
6.
Esch, Harald L., et al.. (2016). Reactivity against DNA bases despite previous conjugation to glutathione – A new mechanism of toxicity for α,β-unsaturated carbonyls?. Toxicology Letters. 258. S254–S254. 1 indexed citations
7.
Kaiser, Marcel, J.-C. Rybak, Klaus Müller‐Buschbaum, et al.. (2016). Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity. Antimicrobial Agents and Chemotherapy. 60(8). 4442–4452. 17 indexed citations
8.
Esch, Harald L., et al.. (2015). Mutagenic potential of the isoflavone irilone in cultured V79 cells. Toxicology Letters. 234(2). 81–91. 2 indexed citations
9.
Esch, Harald L., et al.. (2015). Data in support of the mutagenic potential of the isoflavone irilone in cultured V79 cells. Data in Brief. 4. 474–487. 1 indexed citations
10.
11.
Esch, Harald L., Gabriele Pradel, Leane Lehmann, et al.. (2013). A primaquine–chloroquine hybrid with dual activity against Plasmodium liver and blood stages. International Journal of Medical Microbiology. 303(8). 539–547. 34 indexed citations
12.
Esch, Harald L., et al.. (2013). The isoflavone irilone contributes to the estrogenic potential of dietary supplements containing red clover. Archives of Toxicology. 88(2). 309–321. 18 indexed citations
13.
Ball, Nicholas, Stuart Z. Cagen, Juan-Carlos Carrillo, et al.. (2010). Comparative testing for the identification of skin-sensitizing potentials of nonionic sugar lipid surfactants. Regulatory Toxicology and Pharmacology. 58(2). 301–307. 26 indexed citations
14.
Esch, Harald L., et al.. (2010). 3-Methylcholanthrene (3-MC) and 4-chlorobiphenyl (PCB3) genotoxicity is gender-related in Fischer 344 transgenic rats. Environment International. 36(8). 970–979. 10 indexed citations
15.
Basketter, David, Nicholas Ball, Stuart Z. Cagen, et al.. (2009). Application of a weight of evidence approach to assessing discordant sensitisation datasets: Implications for REACH. Regulatory Toxicology and Pharmacology. 55(1). 90–96. 27 indexed citations
16.
Mehling, Annette, Nicholas Ball, Harald L. Esch, et al.. (2007). Discordant results between the LLNA and Guinea pig tests: Is the LLNA overestimating the sensitisation potential for certain chemicals?. Toxicology Letters. 172. S8–S9. 1 indexed citations
17.
Ludewig, Gabriele, Leane Lehmann, Harald L. Esch, & Larry W. Robertson. (2007). Metabolic activation of PCBs to carcinogens in vivo—A review. Environmental Toxicology and Pharmacology. 25(2). 241–246. 71 indexed citations
18.
Lehmann, Leane, Harald L. Esch, Patricia Kirby, Larry W. Robertson, & Gabriele Ludewig. (2006). 4-Monochlorobiphenyl (PCB3) induces mutations in the livers of transgenic Fisher 344 rats. Carcinogenesis. 28(2). 471–478. 43 indexed citations
19.
Lehmann, Leane, et al.. (2005). Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells. Toxicology Letters. 158(1). 72–86. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026